Evidence map›Paper›PMID 28732082›Full record

ArticlePloS one2017

Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation.

Jason Glover, Tsz-Kwong Man, Donald A Barkauskas, David Hall, Tanya Tello, Mary Beth Sullivan, Richard Gorlick, Katherine Janeway, Holcombe Grier, Ching Lau and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Advancing therapy for osteosarcoma.Nature reviews. Clinical oncology · 2021
    Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Jason GloverChildren's Cancer and Blood Disorders Program, Randall Children's Hospital, Portland, Oregon, United States of America.
Tsz-Kwong ManDepartment of Pediatrics, Baylor College of Medicine, and Texas Children's Cancer Center, Houston, Texas, United States of America.
Donald A BarkauskasDepartment of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
David HallQuadW-COG Childhood Sarcoma Biostatistics and Annotation Office, Children's Oncology Group, Monrovia, California, United States of America.
Tanya TelloQuadW-COG Childhood Sarcoma Biostatistics and Annotation Office, Children's Oncology Group, Monrovia, California, United States of America.
Mary Beth SullivanQuadW-COG Childhood Sarcoma Biostatistics and Annotation Office, Children's Oncology Group, Monrovia, California, United States of America.
Richard GorlickDepartment of Pediatrics, University of Texas, MD Anderson Cancer Center, Houston, Texas, United States of America.
Katherine JanewayDepartment of Pediatrics, Harvard Medical School, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States of America.
Holcombe GrierDepartment of Pediatrics, Harvard Medical School, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States of America.
Ching LauCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, Connecticut, United States of America.
Jeffrey A ToretskyDepartment of Oncology, Georgetown University Medical Center, Washington DC, United States of America.
Scott C BorinsteinDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Chand KhannaEthos Discovery in Washington DC and Ethos Veterinary Health, Woburn, Massachusetts, United States of America.
Timothy M FanDepartment of Veterinary Clinical Medicine, University of Illinois, Urbana, Illinois, United States of America.ORCID http://orcid.org/0000-0003-2510-7050
COG Osteosarcoma Biology Group
Children's Oncology Group · CHHarvard University · USBaylor College of Medicine · USConnecticut Children's Medical Center · USGeorgetown University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Illinois Urbana-Champaign · USUniversity of Southern California · USVanderbilt University Medical Center · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

The prospective banking of osteosarcoma tissue samples to promote research endeavors has been realized through the establishment of a nationally centralized biospecimen repository, the Children's Oncology Group (COG) biospecimen bank located at the Biopathology Center (BPC)/Nationwide Children's Hospital in Columbus, Ohio. Although the physical inventory of osteosarcoma biospecimens is substantive (>15,000 sample specimens), the nature of these resources remains exhaustible. Despite judicious allocation of these high-value biospecimens for conducting sarcoma-related research, a deeper understanding of osteosarcoma biology, in particular metastases, remains unrealized. In addition the identification and development of novel diagnostics and effective therapeutics remain elusive. The QuadW-COG Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) has developed the High Dimensional Data (HDD) platform to complement the existing physical inventory and to promote in silico hypothesis testing in sarcoma biology. The HDD is a relational biologic database derived from matched osteosarcoma biospecimens in which diverse experimental readouts have been generated and digitally deposited. As proof-of-concept, we demonstrate that the HDD platform can be utilized to address previously unrealized biologic questions though the systematic juxtaposition of diverse datasets derived from shared biospecimens. The continued population of the HDD platform with high-value, high-throughput and mineable datasets allows a shared and reusable resource for researchers, both experimentalists and bioinformatics investigators, to propose and answer questions in silico that advance our understanding of osteosarcoma biology.

Indexed as

Biomedical ResearchBone NeoplasmsComputer SimulationDatabases, FactualOsteosarcomaTissue BanksComputational BiologyDEAD-box RNA HelicasesHumansInsulin-Like Growth Factor Binding Protein 2Membrane ProteinsMicroarray AnalysisMinor Histocompatibility AntigensModels, BiologicalRNAUbiquitin ThiolesteraseDDX3Y protein, humanDEAD-box RNA HelicasesIGFBP2 protein, humanInsulin-Like Growth Factor Binding Protein 2Membrane ProteinsMinor Histocompatibility AntigensRNASMIM14 protein, humanUbiquitin ThiolesteraseUSP9Y protein, human

Identifiers

PMID28732082
PMCPMC5521774
OpenAlexW2737210309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.